Study of the Clinical Activity, Safety, and Tolerability of SRT2104 in Subjects With Moderate to Severe Plaque-Type Psoriasis
Clinical trial NCT01154101 · COMPLETED
Trial details
- NCT number
- NCT01154101
- Sponsor
- Sirtris, a GSK Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-06-07
- Primary completion
- 2011-11-09
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.